EUVIMEDEUVIMED entdecken
Crossref

Molecular Docking, Drug-likeness, and DFT study of benzimidazole derivatives as AT1 antagonist activity

Deepti Mishra, Jitendra Sainy, Rajesh Sharma

International Journal of Drug Delivery Technology · 30.05.2026 · 16 (40s)

DOI: 10.25258/ijddt.16.40s.124 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 30.05.2026. Verfasst von Deepti Mishra und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study employed molecular docking, ADME (absorption, distribution, metabolism, and excretion) and density functional theory (DFT), evaluations to investigate the binding characteristics, electronic features, stability, and drug-likeness of benzimidazole derivatives as potential angiotensin type I (AT1) receptor antagonist. Molecular Docking were conducted via the Molegro Virtual Docker 7.0 (MVD) platform, whereas Pharmacokinetic and Pharmacodynamic assessments were executed with the SwissADME webserver. The ADME profile showed that all of the drugs that were studied had good pharmacokinetic and oral bioavailability properties. In-silico results showed that docking and DFT analyses found that compound 31 was a good structural foundation for further research into drugs design and development.

Zitieren

APA

Mishra, D., Sainy, J., & Sharma, R. (2026). Molecular Docking, Drug-likeness, and DFT study of benzimidazole derivatives as AT1 antagonist activity. International Journal of Drug Delivery Technology, 16(40s). https://doi.org/10.25258/ijddt.16.40s.124

Vancouver

Mishra D, Sainy J, Sharma R. Molecular Docking, Drug-likeness, and DFT study of benzimidazole derivatives as AT1 antagonist activity. International Journal of Drug Delivery Technology. 2026;16(40s). doi:10.25258/ijddt.16.40s.124

BibTeX
@article{Mishra2026,
  author = {Mishra, Deepti and Sainy, Jitendra and Sharma, Rajesh},
  title = {Molecular Docking, Drug-likeness, and DFT study of benzimidazole derivatives as AT1 antagonist activity},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {40s},
  doi = {10.25258/ijddt.16.40s.124}
}
Kostenlos starten →